Pan-cancer analysis of a novel indicator of necroptosis with its application in human cancer
Open Access
- 26 September 2022
- journal article
- research article
- Published by Impact Journals, LLC in Aging
- Vol. 14 (18) , 7587-7616
Abstract
As a type of programmed cell death, necroptosis is thought to play a dual role in tumorigenesis. However, a comprehensive assessment of necroptosis-related regulators across human cancers has not been reported. Therefore, in this study, we established a quantitative index to evaluate the necroptosis rate and determine its correlations with clinical prognosis, signaling pathways and molecular features, immune cell infiltration and regulation, immunotherapy, and chemotherapy sensitivity across cancers. Our results indicated that the necroptosis score can act as a favorable or risky prognostic factor in various cancer types. A gene set variation analysis suggested that necroptosis is significantly associated with immune- and inflammation-related signaling pathways, cell growth and apoptosis, and energy metabolism. Furthermore, necroptosis can affect the tumor microenvironment and immunity regulation, and the effect of necroptosis on immunity is different in different tumor types. There is crosstalk between components of necroptosis, pyroptosis, ferroptosis and autophagy pathways in multiple types of cancers. Finally, the necroptosis rate can be an indicator of immunotherapy effectiveness in multiple cancers and can affect the chemotherapy sensitivity of cancer cells. Our study presents a characterization of necroptosis across human cancers, highlights the potential necroptotic effects on immune regulation, and provides new insights into the development of individualized tumor treatments and clinical applications of immunotherapy.Keywords
This publication has 45 references indexed in Scilit:
- Cell Death Conversion under Hypoxic Condition in Tumor Development and TherapyInternational Journal of Molecular Sciences, 2015
- Death Ligands and Granulysin: Mechanisms of Tumor Cell Death Induction and Therapeutic OpportunitiesImmunotherapy, 2015
- Necroptosis and its role in inflammationNature, 2015
- RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathwayNature Immunology, 2014
- RIP3 is downregulated in human myeloid leukemia cells and modulates apoptosis and caspase-mediated p65/RelA cleavageCell Death & Disease, 2014
- Signaling in Innate Immunity and InflammationCold Spring Harbor Perspectives in Biology, 2012
- Immunity, Inflammation, and CancerCell, 2010
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1Nature, 2009
- Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injuryNature Chemical Biology, 2005
- Apoptosis and diseaseThe Lancet, 1993